World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
38
Citations
5116
World Ranking
8601
National Ranking
3657

Richard Grondin publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Richard Grondin sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 67 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Richard Grondin D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Grondin sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 38 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Richard Grondin is affiliated with the University of Kentucky in the United States. Their research primarily spans the fields of Medicine and Neuroscience, with a focus on subfields including Cellular and Molecular Neuroscience, Psychiatry and Mental Health, Neurology, and Radiology, Nuclear Medicine, and Imaging.

The scientist's recent publications demonstrate a concentration on neurological disorders and treatments, cerebrospinal fluid and hydrocephalus, epilepsy research and treatment, as well as advanced MRI techniques and nerve injury and regeneration. Key topics related to their work include:

  • Cerebrospinal fluid and hydrocephalus
  • Epilepsy research and treatment
  • Neurological disorders and treatments
  • Advanced MRI Techniques and Applications
  • Nerve injury and regeneration

Grondin has authored scholarly articles across several publication venues, notably:

  • Journal of Neuroscience Methods
  • Medical Research Archives
  • Applied Sciences

Their recent papers include:

  • "In-vitro and in-vivo performance studies of a porous infusion catheter designed for intraparenchymal delivery of therapeutic agents of varying size," 2022, Journal of Neuroscience Methods
  • "Surgical methodology and protocols for preventing implanted cerebral catheters from becoming obstructed during and after neurosurgery," 2020, Journal of Neuroscience Methods
  • "Comparative Studies of Continuous Versus Pulsatile Delivery of a Novel Mammalian Cell-Derived Variant of GDNF (GDNFv) into the Rhesus Macaque Striatum," 2024, Medical Research Archives
  • "Limosilactobacillus reuteri in Pediatric Oral Health: A Systematic Review," 2025, Applied Sciences

Frequent collaborators in Grondin's research include Greg A. Gerhardt, François Pomerleau, Jorge E. Quintero, Yi Ai, and Don M. Gash.

Best Publications

  • Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease

    Navin Maswood;Jennifer Young;Edward Tilmont;Zhiming Zhang

  • Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.

    R. Grondin;P.J. Bédard;A. Hadj Tahar;L. Grégoire

  • Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys

    Richard Grondin;Zhiming Zhang;Ai Yi;Wayne A. Cass

  • Point source concentration of GDNF may explain failure of phase II clinical trial.

    Michael Francis Salvatore;Yi Ai;Brent Fischer;Amanda M. Zhang

  • Chronic Alterations in Dopaminergic Neurotransmission Produce a Persistent Elevation of ΔFosB-like Protein(s) in both the Rodent and Primate Striatum

    J P Doucet;Y Nakabeppu;P J Bedard;B T Hope

  • Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum

    Richard Grondin;Michael D. Kaytor;Yi Ai;Peter T. Nelson

  • Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson’s disease

    R. Grondin;Don M. Gash

  • Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.

    Yi Ai;William Markesbery;Zhiming Zhang;Richard Grondin

  • Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys.

    Richard Grondin;Wayne A. Cass;Zhiming Zhang;John A. Stanford

  • Widespread suppression of huntingtin with convection-enhanced delivery of siRNA.

    David K. Stiles;Zhiming Zhang;Pei Ge;Brian Nelson

  • Trophic factor distribution predicts functional recovery in parkinsonian monkeys.

    Don M. Gash;Zhiming Zhang;Yi Ai;Richard Grondin

  • Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys.

    R. Grondin;Abdallah Hadj Tahar;Van Diep Doan;P. Ladure

  • Differential Regulation of Striatal Preproenkephalin and Preprotachykinin mRNA Levels in MPTP‐Lesioned Monkeys Chronically Treated with Dopamine D1 or D2 Receptor Agonists

    Morissette M;Grondin R;Goulet M;Bédard Pj

  • Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment.

    Frédéric Calon;Marc Morissette;Othman Ghribi;Martin Goulet

  • Dopamine-receptor stimulation: biobehavioral and biochemical consequences.

    Frédéric Calon;Abdallah Hadj Tahar;Pierre J. Blanchet;Marc Morissette

  • Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys

    Wayne A. Cass;Richard Grondin;Anders H. Andersen;Zhiming Zhang

  • Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.

    P. J. Blanchet;R. Grondin;P. J. Bédard

  • Motor Slowing and Parkinsonian Signs in Aging Rhesus Monkeys Mirror Human Aging

    Zhiming Zhang;Anders Andersen;Charles Smith;Richard Grondin

  • Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys.

    Navin Maswood;Richard Grondin;Zhiming Zhang;John A Stanford

  • Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms.

    Pierre J Blanchet;Frédéric Calon;Marc Morissette;Abdallah Hadj Tahar

  • D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys.

    Richard Grondin;Van Diep Doan;Laurent Grégoire;Paul J. Bédard

Frequent Co-Authors

Zhiming Zhang
Zhiming Zhang University of Kentucky
Don M. Gash
Don M. Gash University of Kentucky
Greg A. Gerhardt
Greg A. Gerhardt University of Kentucky
Paul J. Bédard
Paul J. Bédard Université Laval
Frédéric Calon
Frédéric Calon Université Laval
Marc Morissette
Marc Morissette Université Laval
Wayne A. Cass
Wayne A. Cass University of Kentucky
Thérèse Di Paolo
Thérèse Di Paolo Université Laval
Peter T. Nelson
Peter T. Nelson University of Kentucky
Charles D. Smith
Charles D. Smith University of Kentucky

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Neuroscience opens doors to many career paths, both in research and applied settings. For those interested in the clinical side, online programs such as psyd programs usa can prepare graduates for psychology practice or counseling careers with a neuroscience focus.

Another pathway is in marriage and family therapy, where a background in neuroscience can be highly valuable. If you're looking for flexible and efficient study options, consider accredited mft program choices online, often designed for fast completion.

Accelerated learning opportunities are available for those eager to enter the workforce quickly. Explore 2 year accelerated bachelor degrees in relevant fields that help you build foundational knowledge for neuroscience-related careers.

Salary potential can also be a deciding factor. Review your options with the best bachelor degrees for high-earning opportunities, many of which intersect with neuroscience, psychology, and healthcare professions.

Best Scientists Citing Richard Grondin

Trending Scientists

Recently Published Articles